Bayer rushes support to Ukraine staff, helping with cash and housing as Russians attack major cities
Bayer execs covered all the major pocketbook issues you’d expect in its Q4 call with analysts today. But clearly the invasion of Ukraine — and the widening global crisis that has developed as bombs fall on a civilian population — has captured their attention. And it became a central focus in their presentation today.
“Before we go into the business performance,” Bayer CEO Werner Baumann said, “let me start with what is certainly top of mind for all of us. With the Russian invasion of Ukraine, the geopolitical order is shaken and we are deeply shocked and concerned with what is happening to the Ukrainian people. This war is no less than a threat to our freedom and democracy and we at Bayer condemn in the most vigorous way, this Russian attack.”
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.